Boston
November 13-15, 2023

Early Bird Closes on March 31, 2023 | Register Now and Save upto $500

About AMC2023 Conference

Hilton Boston/Woburn, November 13-15, 2023

The Antibody Manufacturing and Commercialization Summit (AMC2023) is focused on the development and commercialization of antibody-based therapies. AMC2023 brings together experts from the pharmaceutical and biotechnology industries, academia, and government to discuss current challenges and opportunities in the field of antibody research and development. Topics of discussion includes the latest advances in antibody production, purification and formulation, regulatory challenges, clinical development, and commercialization strategies. AMC2023 provides a platform for attendees to network with peers, learn about new technologies and techniques, and gain insights into the future of the antibody industry.

Why Attend AMC2023?

Networking opportunities: Attendees have the chance to network with experts, researchers, and other professionals from the pharmaceutical, biotechnology, and academia communities.
Stay informed on the latest advancements: AMC2023 provides a platform for attendees to learn about the latest advances in antibody research, development, and commercialization.
Gain insights into industry trends: Participants can gain a better understanding of the current and future trends in the antibody industry, as well as the challenges and opportunities that exist.
Learn from experts: AMC2023 features keynote speakers, panel discussions, and presentations from leading experts in the field of antibody research and development.
Opportunity to share knowledge: Attendees have the opportunity to share their own knowledge and experiences with others and engage in discussions on key topics in the field.

Understand

The technology and innovation behind innovative treatments with the power to transform healthcare.

Connect

With industry leaders responsible for the big decisions in areas such as investment, innovation and market access.

Discover

New ideas to support business transformation and maximise return on investment.

BSC’s Previous Speakers

David Anderson

Co-Founder & Chief Scientific Officer, VBI Vaccines

Jason Berg

Executive Director, Project Management, Vaccines, PPD, part of Thermo Fisher Scientific

Giles Platford

President, Plasma-Derived Therapies Business Unit, Takeda Pharmaceutical Company Ltd.

Ron Jortner

Founder|CEO, Aspire Biosciences

Debbie Drane

SVP of Global Commercial Development & TA Strategy, CSL Behring

Jerome Kim

Director General, International Vaccine Institute

Jeff Gilmore

Chief Executive Officer, cGMPNow

Charlene Son Rigby

CEO, RARE-X

Lori Panther

Vice President of Clinical Development, Infectious Diseases, Moderna

Angus Sinclair

Senior Vice President Immuno-Oncology, IGM Biosciences

Alexander Rumyantsev

Therapeutic Area Head, Infectious Diseases, Vaxxinity

Mark J. Newman

CSO, GeoVax Inc.

Timothy J. Miller

Cofounder, President & CEO, Forge Biologics

Sareina Wu

Founder & CSO, GenomeFrontier Therapeutics, Inc.

Amanda Moore

Chief Executive Officer, Angelman Syndrome Foundation

Who attends AMC2023:

The AMC2023 Summit is designed for professionals in the pharmaceutical, biotechnology, and academic communities, including:

Researchers and scientists: Including those involved in the discovery, engineering, production, and purification of antibodies.
Clinicians and physicians: Including those involved in the clinical development and testing of antibody-based therapies.
Regulatory affairs and quality professionals: Including those responsible for ensuring the regulatory compliance and quality control of antibody-based therapies.
Commercial and business development professionals: Including those involved in the commercialization, pricing, and reimbursement of antibody-based therapies.
Investors and financiers: Including venture capitalists, investment bankers, and other financial experts interested in the antibody industry.

Topics covered at AMC2023

Antibody discovery and engineering: Discussion of new methods for discovering and engineering antibodies, including phage display, yeast display, and other platforms.
Antibody production and purification: Overview of current methods for producing and purifying antibodies, including cell culture, transfection, and antibody engineering technologies.
Formulation and drug delivery: Examination of various formulation and delivery methods for antibodies, including intravenous, subcutaneous, and oral delivery, and their impact on efficacy and safety.
Clinical development and regulatory challenges: Discussion of the clinical development process for antibody-based therapies, including pre-clinical studies, clinical trials, and regulatory challenges.
Commercialization strategies: Overview of the commercialization process for antibody-based therapies, including market access, pricing, and reimbursement strategies.
Emerging trends and technologies: Discussion of new trends and technologies in the antibody industry, including the use of antibodies for non-oncological diseases, combination therapies, and the use of biosimilars.

Become a Sponsor or Exhibitor

Antibody Manufacturing And Commercialization 2023 provides the much-needed platform on which industry executives can network, connect, and learn from each other as well as meet potential industry partners.

Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.

With our extensive marketing experience and strategy, your partnership with AMC2023 will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.

For sponsorship and exhibition opportunities, please contact: